Tag: RESTLESS LEGS SYNDROME

Noctrix Raises $33.5M Expanding Leadership to Accelerate U.S. Commercialization of Nidra(R) Therapy for Restless Legs Syndrome
Restless Leg Syndrome Product/Vendor Updates

Noctrix Health Raises $33.5M, Expands Leadership Team of Nidra Therapy for Restless Legs Syndrome (RLS)

Noctrix Health, Inc., the developer of the Nidra® Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS), announced a significant expansion of private financing to accelerate its U.S. commercial launch. The company also announced several key leadership appointments to strengthen its commercial and scientific teams. Financing Update Noctrix Health […]

Noctrix health restless legs syndrome
Research/Studies

Noctrix Health Enrolls First Patient in RLS Wearable Device Trial

Noctrix Health, Inc. announced that the first patient has been enrolled in a multi-center, randomized controlled clinical trial. The RESTFUL Study (ClinicalTrials.gov Identifier: NCT04874155) is a first of its kind two-phase, randomized, double-blind, sham-controlled clinical trial to evaluate the Company’s proprietary wearable NTX100 Neuromodulation System in patients with moderate-severe primary RLS […]

restless legs
Research/Studies

Breakthrough in Treatment of Restless Legs Syndrome

15 November 2018 New research published in The Journal of Physiology presents a breakthrough in the treatment of Restless Legs Syndrome (RLS) RLS is a common condition of the nervous system that causes an overwhelming, irresistible urge to move the legs. Patients complain of unpleasant symptoms such as tingling, burning and painful cramping sensations […]